Martini DJ, Hamieh L, McKay RR, Harshman LC, Brandao R, Norton CK, Steinharter JA, Krajewski KM, Gao X, Schutz FA, McGregor B, Bossé D, Lalani AA, De Velasco G, Michaelson MD, McDermott DF, Choueiri TK
Durable Clinical Benefit in Metastatic Renal Cell Carcinoma Patients Who Discontinue PD-1/PD-L1 Therapy for Immune-Related Adverse Events. Cancer Immunol Res. 2018 04; 6(4):402-408.
Durable Clinical Benefit in Metastatic Renal Cell Carcinoma Patients Who Discontinue PD-1/PD-L1 Therapy for Immune-Related Adverse Events.
Shinagare AB, Krajewski KM, Braschi-Amirfarzan M, Ramaiya NH
Advanced Renal Cell Carcinoma: Role of the Radiologist in the Era of Precision Medicine. Radiology. 2017 08; 284(2):333-351.
Advanced Renal Cell Carcinoma: Role of the Radiologist in the Era of Precision Medicine.
Gosangi B, Davids M, Somarouthu B, Alessandrino F, Giardino A, Ramaiya N, Krajewski K
Cancer imaging : the official publication of the International Cancer Imaging Society
Review of targeted therapy in chronic lymphocytic leukemia: what a radiologist needs to know about CT interpretation. Cancer Imaging. 2018 Apr 18; 18(1):13.
Review of targeted therapy in chronic lymphocytic leukemia: what a radiologist needs to know about CT interpretation.
Krajewski KM, Guo M, Van den Abbeele AD, Yap J, Ramaiya N, Jagannathan J, Heng DY, Atkins MB, McDermott DF, Schutz FA, Pedrosa I, Choueiri TK
Comparison of four early posttherapy imaging changes (EPTIC; RECIST 1.0, tumor shrinkage, computed tomography tumor density, Choi criteria) in assessing outcome to vascular endothelial growth factor-targeted therapy in patients with advanced renal cell carcinoma. Eur Urol. 2011 May; 59(5):856-62.
Comparison of four early posttherapy imaging changes (EPTIC; RECIST 1.0, tumor shrinkage, computed tomography tumor density, Choi criteria) in assessing outcome to vascular endothelial growth factor-targeted therapy in patients with advanced renal cell carcinoma.
Alessandrino F, Shinagare AB, Bossé D, Choueiri TK, Krajewski KM
Radiogenomics in renal cell carcinoma. Abdom Radiol (NY). 2019 06; 44(6):1990-1998.
Alessandrino F, Krajewski KM, Shinagare AB
Update on Radiogenomics of Clear Cell Renal Cell Carcinoma. Eur Urol Focus. 2016 Dec 15; 2(6):572-573.
Update on Radiogenomics of Clear Cell Renal Cell Carcinoma.
Javery O, Krajewski K, O'Regan K, Kis B, Giardino A, Jagannathan J, Ramaiya NH
A to Z of extraskeletal Ewing sarcoma family of tumors in adults: imaging features of primary disease, metastatic patterns, and treatment responses. AJR Am J Roentgenol. 2011 Dec; 197(6):W1015-22.
A to Z of extraskeletal Ewing sarcoma family of tumors in adults: imaging features of primary disease, metastatic patterns, and treatment responses.
Howard S, Jagannathan J, Krajewski K, Giardino A, Zukotynski K, O'Regan K, Ghobrial I, Ramaiya N
Multimodality imaging in amyloidosis. Cancer Imaging. 2012 Apr 27; 12:109-17.
McKay RR, Bossé D, Gray KP, Michaelson MD, Krajewski K, Jacene HA, Walsh M, Bellmunt J, Pomerantz M, Harshman LC, Choueiri TK
Clinical cancer research : an official journal of the American Association for Cancer Research
Radium-223 Dichloride in Combination with Vascular Endothelial Growth Factor-Targeting Therapy in Advanced Renal Cell Carcinoma with Bone Metastases. Clin Cancer Res. 2018 09 01; 24(17):4081-4088.
Radium-223 Dichloride in Combination with Vascular Endothelial Growth Factor-Targeting Therapy in Advanced Renal Cell Carcinoma with Bone Metastases.
Dabydeen DA, Jagannathan JP, Ramaiya N, Krajewski K, Schutz FA, Cho DC, Pedrosa I, Choueiri TK
European journal of cancer (Oxford, England : 1990)
Pneumonitis associated with mTOR inhibitors therapy in patients with metastatic renal cell carcinoma: incidence, radiographic findings and correlation with clinical outcome. Eur J Cancer. 2012 Jul; 48(10):1519-24.
Pneumonitis associated with mTOR inhibitors therapy in patients with metastatic renal cell carcinoma: incidence, radiographic findings and correlation with clinical outcome.
Zukotynski K, Lewis A, O'Regan K, Jacene H, Sakellis C, Krajewski K, Israel D
PET/CT and renal pathology: a blind spot for radiologists? Part 1, primary pathology. AJR Am J Roentgenol. 2012 Aug; 199(2):W163-7.
PET/CT and renal pathology: a blind spot for radiologists? Part 1, primary pathology.
Kim KW, Ramaiya NH, Krajewski KM, Jagannathan JP, Tirumani SH, Srivastava A, Ibrahim N
Ipilimumab associated hepatitis: imaging and clinicopathologic findings. Invest New Drugs. 2013 Aug; 31(4):1071-7.
Ipilimumab associated hepatitis: imaging and clinicopathologic findings.
Mass Compression from Recurrent Lymphoma Mimicking Lower Extremity Cellulitis. Cureus. 2018 Apr 12; 10(4):e2466.
Mass Compression from Recurrent Lymphoma Mimicking Lower Extremity Cellulitis.
Shinagare AB, Krajewski KM, Jagannathan JP, Ramaiya NH
Genitourinary imaging: part 2, role of imaging in medical management of advanced renal cell carcinoma. AJR Am J Roentgenol. 2012 Nov; 199(5):W554-64.
Genitourinary imaging: part 2, role of imaging in medical management of advanced renal cell carcinoma.
Shinagare AB, Krajewski KM, Hornick JL, Zukotynski K, Kurra V, Jagannathan JP, Ramaiya NH
MRI for evaluation of myeloid sarcoma in adults: a single-institution 10-year experience. AJR Am J Roentgenol. 2012 Dec; 199(6):1193-8.
MRI for evaluation of myeloid sarcoma in adults: a single-institution 10-year experience.
Mc Auley G, Jagannathan J, O'Regan K, Krajewski KM, Hornick JL, Butrynski J, Ramaiya N
Extraskeletal osteosarcoma: spectrum of imaging findings. AJR Am J Roentgenol. 2012 Jan; 198(1):W31-7.
Extraskeletal osteosarcoma: spectrum of imaging findings.
Baez JC, Jagannathan JP, Krajewski K, O'Regan K, Zukotynski K, Kulke M, Ramaiya NH
Pheochromocytoma and paraganglioma: imaging characteristics. Cancer Imaging. 2012 May 07; 12:153-62.
Pheochromocytoma and paraganglioma: imaging characteristics.
Saboo SS, Krajewski KM, O'Regan KN, Giardino A, Brown JR, Ramaiya N, Jagannathan JP
Spleen in haematological malignancies: spectrum of imaging findings. Br J Radiol. 2012 Jan; 85(1009):81-92.
Spleen in haematological malignancies: spectrum of imaging findings.
Miksad RA, Lai KC, Stein MC, Healy ME, Rojas R, Krajewski KM, Zhu AX
Imbalance and gait disturbance from tyrosine kinase inhibition in hepatocellular cancer. J Gastrointest Cancer. 2009; 40(3-4):119-22.
Imbalance and gait disturbance from tyrosine kinase inhibition in hepatocellular cancer.
Souza FF, de Angelo M, O'Regan K, Jagannathan J, Jagganathan J, Krajewski K, Ramaiya N
Malignant primary chest wall neoplasms: a pictorial review of imaging findings. Clin Imaging. 2013 Jan-Feb; 37(1):8-17.
Malignant primary chest wall neoplasms: a pictorial review of imaging findings.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Imaging Advances in the Management of Kidney Cancer. J Clin Oncol. 2018 10 29; JCO2018791236.
Imaging Advances in the Management of Kidney Cancer.
Thomas R, Qin L, Alessandrino F, Sahu SP, Guerra PJ, Krajewski KM, Shinagare A
A review of the principles of texture analysis and its role in imaging of genitourinary neoplasms. Abdom Radiol (NY). 2019 07; 44(7):2501-2510.
A review of the principles of texture analysis and its role in imaging of genitourinary neoplasms.
Krajewski K, Siewert B, Yam S, Kressel HY, Kruskal JB
A quality assurance elective for radiology residents. Acad Radiol. 2007 Feb; 14(2):239-45.
A quality assurance elective for radiology residents.
Colonic dilation. AJR Am J Roentgenol. 2009 Nov; 193(5):W363-72.
Bakri A, Shinagare AB, Krajewski KM, Howard SA, Jagannathan JP, Hornick JL, Ramaiya NH
Synovial sarcoma: imaging features of common and uncommon primary sites, metastatic patterns, and treatment response. AJR Am J Roentgenol. 2012 Aug; 199(2):W208-15.
Synovial sarcoma: imaging features of common and uncommon primary sites, metastatic patterns, and treatment response.
Shinagare AB, Howard SA, Krajewski KM, Zukotynski KA, Jagannathan JP, Ramaiya NH
Pneumatosis intestinalis and bowel perforation associated with molecular targeted therapy: an emerging problem and the role of radiologists in its management. AJR Am J Roentgenol. 2012 Dec; 199(6):1259-65.
Pneumatosis intestinalis and bowel perforation associated with molecular targeted therapy: an emerging problem and the role of radiologists in its management.
Choe J, Kim KW, Kim HJ, Kim DW, Kim KP, Hong SM, Ryu JS, Tirumani SH, Krajewski K, Ramaiya N
What Is New in the 2017 World Health Organization Classification and 8th American Joint Committee on Cancer Staging System for Pancreatic Neuroendocrine Neoplasms? Korean J Radiol. 2019 01; 20(1):5-17.
What Is New in the 2017 World Health Organization Classification and 8th American Joint Committee on Cancer Staging System for Pancreatic Neuroendocrine Neoplasms?
Ultrasound staging of rectal cancer. Semin Ultrasound CT MR. 2008 Dec; 29(6):427-32.
O'Regan KN, Jagannathan J, Krajewski K, Zukotynski K, Souza F, Wagner AJ, Ramaiya N
Imaging of liposarcoma: classification, patterns of tumor recurrence, and response to treatment. AJR Am J Roentgenol. 2011 Jul; 197(1):W37-43.
Imaging of liposarcoma: classification, patterns of tumor recurrence, and response to treatment.
Kim KW, Krajewski KM, Jagannathan JP, Nishino M, Shinagare AB, Hornick JL, Ramaiya NH
Cancer of unknown primary sites: what radiologists need to know and what oncologists want to know. AJR Am J Roentgenol. 2013 Mar; 200(3):484-92.
Cancer of unknown primary sites: what radiologists need to know and what oncologists want to know.
Cabral FC, Krajewski KM, Kim KW, Ramaiya NH, Jagannathan JP
Peritoneal lymphomatosis: CT and PET/CT findings and how to differentiate between carcinomatosis and sarcomatosis. Cancer Imaging. 2013 Apr 15; 13:162-70.
Peritoneal lymphomatosis: CT and PET/CT findings and how to differentiate between carcinomatosis and sarcomatosis.
Alessandrino F, DiPiro PJ, Jagannathan JP, Babina G, Krajewski KM, Ramaiya NH, Giardino AA
Multimodality imaging of indolent B cell lymphoma from diagnosis to transformation: what every radiologist should know. Insights Imaging. 2019 Feb 22; 10(1):25.
Multimodality imaging of indolent B cell lymphoma from diagnosis to transformation: what every radiologist should know.
Kim KW, Park SH, Pyo J, Yoon SH, Byun JH, Lee MG, Krajewski KM, Ramaiya NH
Imaging features to distinguish malignant and benign branch-duct type intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis. Ann Surg. 2014 Jan; 259(1):72-81.
Imaging features to distinguish malignant and benign branch-duct type intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis.
Jerome and Nancy Kohlberg Professor of Medicine
Walter S. Kerr, Jr. Distinguished Professor of Surgery
Tirumani SH, Shinagare AB, Sakellis C, Saboo SS, Jagannathan JP, Krajewski KM, Ramaiya NH
Merkel cell carcinoma: a primer for the radiologist. AJR Am J Roentgenol. 2013 Jun; 200(6):1186-96.
Merkel cell carcinoma: a primer for the radiologist.
Nassar AH, Hamieh L, Gray KP, Thorner AR, Fay AP, Lasseter KD, Abou Alaiwi S, Nuzzo PV, Flippot R, Krajewski KM, Signoretti S, Choueiri TK, Kwiatkowski DJ
Mutations and Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma. Mol Cancer Ther. 2020 02; 19(2):690-696.
Mutations and Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma.
Pathoulas JT, Flanagan KE, Walker CJ, Ly A, Krajewski KM, Pupo Wiss I, Senna MM
Subcutaneous metastasis from an atypical pulmonary carcinoid tumor. Dermatol Online J. 2021 May 15; 27(5).
Subcutaneous metastasis from an atypical pulmonary carcinoid tumor.
Rana HQ, Koeller DR, Schwartz A, Manning DK, Schneider KA, Krajewski KM, Choueiri TK, Lindeman NI, Garber JE, Ghazani AA
Pathogenicity of VHL variants in families with non-syndromic von Hippel-Lindau phenotypes: An integrated evaluation of germline and somatic genomic results. Eur J Med Genet. 2021 Dec; 64(12):104359.
Pathogenicity of VHL variants in families with non-syndromic von Hippel-Lindau phenotypes: An integrated evaluation of germline and somatic genomic results.
Hirsch L, Martinez Chanza N, Farah S, Xie W, Flippot R, Braun DA, Rathi N, Thouvenin J, Collier KA, Seront E, de Velasco G, Dzimitrowicz H, Beuselinck B, Xu W, Bowman IA, Lam ET, Abuqayas B, Bilen MA, Varkaris A, Zakharia Y, Harrison MR, Mortazavi A, Barthélémy P, Agarwal N, McKay RR, Brastianos PK, Krajewski KM, Albigès L, Harshman LC, Choueiri TK
Clinical Activity and Safety of Cabozantinib for Brain Metastases in Patients With Renal Cell Carcinoma. JAMA Oncol. 2021 Dec 01; 7(12):1815-1823.
Clinical Activity and Safety of Cabozantinib for Brain Metastases in Patients With Renal Cell Carcinoma.
Kim KW, Ramaiya NH, Krajewski KM, Shinagare AB, Howard SA, Jagannathan JP, Ibrahim N
Ipilimumab-associated colitis: CT findings. AJR Am J Roentgenol. 2013 May; 200(5):W468-74.
Ipilimumab-associated colitis: CT findings.
Kim KW, Shinagare AB, Krajewski KM, Howard SA, Jagannathan JP, Zukotynski K, Ramaiya NH
Update on imaging of vulvar squamous cell carcinoma. AJR Am J Roentgenol. 2013 Jul; 201(1):W147-57.
Update on imaging of vulvar squamous cell carcinoma.
Shinagare AB, Jagannathan JP, Krajewski KM, Ramaiya NH
Liver metastases in the era of molecular targeted therapy: new faces of treatment response. AJR Am J Roentgenol. 2013 Jul; 201(1):W15-28.
Liver metastases in the era of molecular targeted therapy: new faces of treatment response.
Park HJ, Qin L, Bakouny Z, Krajewski KM, Van Allen EM, Choueiri TK, Shinagare AB
Computed Tomography Texture Analysis for Predicting Clinical Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors. Oncologist. 2022 05 06; 27(5):389-397.
Computed Tomography Texture Analysis for Predicting Clinical Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors.
Lee LK, Krajewski KM, Suarez-Weiss KE, Silverman SG, Shinagare AB
Current problems in diagnostic radiology
Learning From Experience- Confronting Challenges and Adapting to Change in a Large Academic Abdominal Radiology Practice: Insights From a Faculty Retreat. Curr Probl Diagn Radiol. 2022 Nov-Dec; 51(6):818-822.
Learning From Experience- Confronting Challenges and Adapting to Change in a Large Academic Abdominal Radiology Practice: Insights From a Faculty Retreat.
Hematology/oncology clinics of North America
Insights into Renal Cell Carcinoma with Novel Imaging Approaches. Hematol Oncol Clin North Am. 2023 10; 37(5):863-875.
Insights into Renal Cell Carcinoma with Novel Imaging Approaches.
Shy ME, Chen L, Swan ER, Taube R, Krajewski KM, Herrmann D, Lewis RA, McDermott MP
Neuropathy progression in Charcot-Marie-Tooth disease type 1A. Neurology. 2008 Jan 29; 70(5):378-83.
Neuropathy progression in Charcot-Marie-Tooth disease type 1A.
Jammihal T, Saliby RM, Labaki C, Soulati H, Gallegos J, Peris A, McCurry D, Yu C, Shah V, Poduval D, El Zarif T, El Ahmar N, Laimon YN, Eid M, Sheshdeh AB, Krajewski KM, Büttner FA, Schwab M, Heng D, Casellas RC, Rai K, Zacharias Millward NM, Msaouel P, Karam J, Signoretti S, Van Allen E, Choueiri TK, Braun DA, Shukla SA
Immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinoma. Nat Cancer. 2025 Feb; 6(2):372-384.
Immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinoma.
Kim KW, Krajewski KM, Nishino M, Jagannathan JP, Shinagare AB, Tirumani SH, Ramaiya NH
Update on the management of gastroenteropancreatic neuroendocrine tumors with emphasis on the role of imaging. AJR Am J Roentgenol. 2013 Oct; 201(4):811-24.
Update on the management of gastroenteropancreatic neuroendocrine tumors with emphasis on the role of imaging.
Tirumani SH, Jagannathan JP, Krajewski KM, Shinagare AB, Jacene H, Ramaiya NH
Imatinib and beyond in gastrointestinal stromal tumors: A radiologist's perspective. AJR Am J Roentgenol. 2013 Oct; 201(4):801-10.
Imatinib and beyond in gastrointestinal stromal tumors: A radiologist's perspective.
Tirumani SH, Jagannathan JP, Shinagare AB, Kim Kw, Krajewski KM, Ramaiya NH
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Acute pancreatitis associated with molecular targeted therapies: a retrospective review of the clinico-radiological features, management and outcome. Pancreatology. 2013 Sep-Oct; 13(5):461-7.
Acute pancreatitis associated with molecular targeted therapies: a retrospective review of the clinico-radiological features, management and outcome.
Tirumani SH, Krajewski KM, Shinagare AB, Jagannathan JP, Ramaiya NH
Gallbladder complications associated with molecular targeted therapies: clinical and imaging features. Clin Imaging. 2014 Jan-Feb; 38(1):50-5.
Gallbladder complications associated with molecular targeted therapies: clinical and imaging features.
Kamran SC, Shinagare AB, Howard SA, Nishino M, Hornick JL, Krajewski KM, Ramaiya NH
Intrathoracic malignant peripheral nerve sheath tumors: imaging features and implications for management. Radiol Oncol. 2013; 47(3):230-8.
Intrathoracic malignant peripheral nerve sheath tumors: imaging features and implications for management.
Najem EJ, Shaikh MJS, Shinagare AB, Krajewski KM
Navigating advanced renal cell carcinoma in the era of artificial intelligence. Cancer Imaging. 2025 Feb 18; 25(1):16.
Navigating advanced renal cell carcinoma in the era of artificial intelligence.
Tirumani SH, Shinagare AB, Jagannathan JP, Krajewski KM, Ramaiya NH, Raut CP
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Radiologic assessment of earliest, best, and plateau response of gastrointestinal stromal tumors to neoadjuvant imatinib prior to successful surgical resection. Eur J Surg Oncol. 2014 Apr; 40(4):420-8.
Radiologic assessment of earliest, best, and plateau response of gastrointestinal stromal tumors to neoadjuvant imatinib prior to successful surgical resection.
Tirumani SH, Shinagare AB, Jagannathan JP, Krajewski KM, Ramaiya NH
Multidetector-row CT of tumour-bowel fistula: Experience at a tertiary cancer centre. Clin Radiol. 2014 Feb; 69(2):e100-7.
Multidetector-row CT of tumour-bowel fistula: Experience at a tertiary cancer centre.
Beyond the AJR: Artificial Intelligence for CT Characterization of Benign Indolent, Malignant Indolent, and Malignant Aggressive Renal Masses. AJR Am J Roentgenol. 2025 Dec; 225(6):e2533095.
Beyond the AJR: Artificial Intelligence for CT Characterization of Benign Indolent, Malignant Indolent, and Malignant Aggressive Renal Masses.
Cooley C, Nishino M, Jagannathan J, Ramaiya N, Di Salvo D, Krajewski KM
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine
Clinical problem solving: utility of sonography in oncologic patients. J Ultrasound Med. 2014 Jan; 33(1):9-22.
Clinical problem solving: utility of sonography in oncologic patients.
Tirumani H, Rosenthal MH, Tirumani SH, Shinagare AB, Krajewski KM, Ramaiya NH
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus
Imaging of uncommon esophageal malignancies. Dis Esophagus. 2015 Aug-Sep; 28(6):552-9.
Imaging of uncommon esophageal malignancies.
Tirumani SH, Shinagare AB, Jagannathan JP, Krajewski KM, Munshi NC, Ramaiya NH
MRI features of extramedullary myeloma. AJR Am J Roentgenol. 2014 Apr; 202(4):803-10.
Juan YH, Saboo SS, Tirumani SH, Khandelwal A, Shinagare AB, Ramaiya N, Krajewski KM
Malignant skin and subcutaneous neoplasms in adults: multimodality imaging with CT, MRI, and 18F-FDG PET/CT. AJR Am J Roentgenol. 2014 May; 202(5):W422-38.
Malignant skin and subcutaneous neoplasms in adults: multimodality imaging with CT, MRI, and 18F-FDG PET/CT.
Krajewski KM, Lewis RA, Fuerst DR, Turansky C, Hinderer SR, Garbern J, Kamholz J, Shy ME
Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A. Brain. 2000 Jul; 123 ( Pt 7):1516-27.
Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A.
Shy ME, Siskind C, Swan ER, Krajewski KM, Doherty T, Fuerst DR, Ainsworth PJ, Lewis RA, Scherer SS, Hahn AF
CMT1X phenotypes represent loss of GJB1 gene function. Neurology. 2007 Mar 13; 68(11):849-55.
CMT1X phenotypes represent loss of GJB1 gene function.
Krajewski KM, Nishino M, Franchetti Y, Ramaiya NH, Van den Abbeele AD, Choueiri TK
Intraobserver and interobserver variability in computed tomography size and attenuation measurements in patients with renal cell carcinoma receiving antiangiogenic therapy: implications for alternative response criteria. Cancer. 2014 Mar 01; 120(5):711-21.
Intraobserver and interobserver variability in computed tomography size and attenuation measurements in patients with renal cell carcinoma receiving antiangiogenic therapy: implications for alternative response criteria.
Krajewski KM, Franchetti Y, Nishino M, Fay AP, Ramaiya N, Van den Abbeele AD, Choueiri TK
10% Tumor diameter shrinkage on the first follow-up computed tomography predicts clinical outcome in patients with advanced renal cell carcinoma treated with angiogenesis inhibitors: a follow-up validation study. Oncologist. 2014 May; 19(5):507-14.
10% Tumor diameter shrinkage on the first follow-up computed tomography predicts clinical outcome in patients with advanced renal cell carcinoma treated with angiogenesis inhibitors: a follow-up validation study.
Choueiri TK, Jacobus S, Bellmunt J, Qu A, Appleman LJ, Tretter C, Bubley GJ, Stack EC, Signoretti S, Walsh M, Steele G, Hirsch M, Sweeney CJ, Taplin ME, Kibel AS, Krajewski KM, Kantoff PW, Ross RW, Rosenberg JE
Neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin with pegfilgrastim support in muscle-invasive urothelial cancer: pathologic, radiologic, and biomarker correlates. J Clin Oncol. 2014 Jun 20; 32(18):1889-94.
Neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin with pegfilgrastim support in muscle-invasive urothelial cancer: pathologic, radiologic, and biomarker correlates.
Eid S, Al-Yousef AS, Kim KW, Yoon S, Nawfal R, Bellmunt J, Choueiri TK, Krajewski KM
State-of-the-Art Imaging in Antibody-Drug Conjugate Treatment for Advanced Bladder Cancer. Korean J Radiol. 2025 Oct; 26(10):959-972.
State-of-the-Art Imaging in Antibody-Drug Conjugate Treatment for Advanced Bladder Cancer.
Tapper EB, Krajewski K, Lai M, Challies T, Kane R, Afdhal N, Lau D
Simple non-invasive biomarkers of advanced fibrosis in the evaluation of non-alcoholic fatty liver disease. Gastroenterol Rep (Oxf). 2014 Nov; 2(4):276-80.
Simple non-invasive biomarkers of advanced fibrosis in the evaluation of non-alcoholic fatty liver disease.
Kapoor N, Shinagare AB, Jagannathan JP, Shah SH, Krajewski KM, Hornick JL, Ramaiya NH
Clinical and radiologic features of extraskeletal myxoid chondrosarcoma including initial presentation, local recurrence, and metastases. Radiol Oncol. 2014 Sep; 48(3):235-42.
Clinical and radiologic features of extraskeletal myxoid chondrosarcoma including initial presentation, local recurrence, and metastases.
Cabral FC, Krajewski KM, Rosenthal MH, Hirsch MS, Howard SA
Teratoma with malignant transformation: report of three cases and review of the literature. Clin Imaging. 2014 Sep-Oct; 38(5):589-93.
Teratoma with malignant transformation: report of three cases and review of the literature.
Tirumani SH, Kim KW, Nishino M, Howard SA, Krajewski KM, Jagannathan JP, Cleary JM, Ramaiya NH, Shinagare AB
Radiographics : a review publication of the Radiological Society of North America, Inc
Update on the role of imaging in management of metastatic colorectal cancer. Radiographics. 2014 Nov-Dec; 34(7):1908-28.
Update on the role of imaging in management of metastatic colorectal cancer.
Rohatgi S, Jagannathan JP, Rosenthal MH, Kim KW, Ramaiya NH, Krajewski KM
Vascular toxicity associated with chemotherapy and molecular targeted therapy: what should a radiologist know? AJR Am J Roentgenol. 2014 Dec; 203(6):1353-62.
Vascular toxicity associated with chemotherapy and molecular targeted therapy: what should a radiologist know?
Baheti AD, Tirumani SH, Giardino A, Rosenthal MH, Tirumani H, Krajewski K, Ramaiya NH
Basal cell carcinoma: a comprehensive review for the radiologist. AJR Am J Roentgenol. 2015 Feb; 204(2):W132-40.
Basal cell carcinoma: a comprehensive review for the radiologist.
Rohatgi S, Howard SA, Tirumani SH, Ramaiya NH, Krajewski KM
Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes
Multimodality Imaging of Tumour Thrombus. Can Assoc Radiol J. 2015 May; 66(2):121-9.
Multimodality Imaging of Tumour Thrombus.
Kim KW, Shinagare AB, Krajewski KM, Pyo J, Tirumani SH, Jagannathan JP, Ramaiya NH
Fluid retention associated with imatinib treatment in patients with gastrointestinal stromal tumor: quantitative radiologic assessment and implications for management. Korean J Radiol. 2015 Mar-Apr; 16(2):304-13.
Fluid retention associated with imatinib treatment in patients with gastrointestinal stromal tumor: quantitative radiologic assessment and implications for management.
Tirumani SH, Fairchild A, Krajewski KM, Nishino M, Howard SA, Baheti AD, Rosenthal MH, Jagannathan JP, Shinagare AB, Ramaiya NH
Anti-VEGF molecular targeted therapies in common solid malignancies: comprehensive update for radiologists. Radiographics. 2015 Mar-Apr; 35(2):455-74.
Anti-VEGF molecular targeted therapies in common solid malignancies: comprehensive update for radiologists.
Esophageal Carcinoma: Current Concepts in the Role of Imaging in Staging and Management. Can Assoc Radiol J. 2015 May; 66(2):130-9.
Esophageal Carcinoma: Current Concepts in the Role of Imaging in Staging and Management.
Krajewski KM, Nishino M, Ramaiya NH, Choueiri TK
RECIST 1.1 compared with RECIST 1.0 in patients with advanced renal cell carcinoma receiving vascular endothelial growth factor-targeted therapy. AJR Am J Roentgenol. 2015 Mar; 204(3):W282-8.
RECIST 1.1 compared with RECIST 1.0 in patients with advanced renal cell carcinoma receiving vascular endothelial growth factor-targeted therapy.
Howard SA, Rosenthal MH, Jagannathan JP, Krajewski KM, Shinagare AB, Ramaiya NH, Tirumani SH
Beyond the vascular endothelial growth factor axis: update on role of imaging in nonantiangiogenic molecular targeted therapies in oncology. AJR Am J Roentgenol. 2015 May; 204(5):919-32.
Beyond the vascular endothelial growth factor axis: update on role of imaging in nonantiangiogenic molecular targeted therapies in oncology.
Fairchild A, Tirumani SH, Rosenthal MH, Howard SA, Krajewski KM, Nishino M, Shinagare AB, Jagannathan JP, Ramaiya NH
Hormonal therapy in oncology: a primer for the radiologist. AJR Am J Roentgenol. 2015 Jun; 204(6):W620-30.
Hormonal therapy in oncology: a primer for the radiologist.
Grünwald V, McKay RR, Krajewski KM, Kalanovic D, Lin X, Perkins JJ, Simantov R, Choueiri TK
Depth of remission is a prognostic factor for survival in patients with metastatic renal cell carcinoma. Eur Urol. 2015 May; 67(5):952-8.
Depth of remission is a prognostic factor for survival in patients with metastatic renal cell carcinoma.
Baheti AD, Shinagare AB, O'Neill AC, Krajewski KM, Hornick JL, George S, Ramaiya NH, Tirumani SH
MDCT and clinicopathological features of small bowel gastrointestinal stromal tumours in 102 patients: a single institute experience. Br J Radiol. 2015 Sep; 88(1053):20150085.
MDCT and clinicopathological features of small bowel gastrointestinal stromal tumours in 102 patients: a single institute experience.
Howard SA, Krajewski KM, Weissman BN, Seltzer SE, Ramaiya NH, Van den Abbeele AD
Journal of the American College of Radiology : JACR
Cancer Imaging Training in the 21st Century: An Overview of Where We Are, and Where We Need To Be. J Am Coll Radiol. 2015 Jul; 12(7):714-20.
Cancer Imaging Training in the 21st Century: An Overview of Where We Are, and Where We Need To Be.
Rohatgi S, Ramaiya NH, Jagannathan JP, Howard SA, Shinagare AB, Krajewski KM
Metastatic Chordoma: Report of the Two Cases and Review of the Literature. Eurasian J Med. 2015 Jun; 47(2):151-4.
Metastatic Chordoma: Report of the Two Cases and Review of the Literature.
Keraliya AR, Krajewski KM, Giardino AA, Tirumani SH, Shinagare AB, Ramaiya NH, Jagannathan JP
Imaging of Nervous System Involvement in Hematologic Malignancies: What Radiologists Need to Know. AJR Am J Roentgenol. 2015 Sep; 205(3):604-17.
Imaging of Nervous System Involvement in Hematologic Malignancies: What Radiologists Need to Know.
Keraliya AR, Krajewski KM, Braschi-Amirfarzan M, Tirumani SH, Shinagare AB, Jagannathan JP, Ramaiya NH
Extracutaneous melanomas: a primer for the radiologist. Insights Imaging. 2015 Dec; 6(6):707-17.
Extracutaneous melanomas: a primer for the radiologist.
Keraliya AR, Rosenthal MH, Krajewski KM, Jagannathan JP, Shinagare AB, Tirumani SH, Ramaiya NH
Imaging of Fluid in Cancer Patients Treated With Systemic Therapy: Chemotherapy, Molecular Targeted Therapy, and Hematopoietic Stem Cell Transplantation. AJR Am J Roentgenol. 2015 Oct; 205(4):709-19.
Imaging of Fluid in Cancer Patients Treated With Systemic Therapy: Chemotherapy, Molecular Targeted Therapy, and Hematopoietic Stem Cell Transplantation.
Albiges L, Fay AP, Xie W, Krajewski K, McDermott DF, Heng DY, Dariane C, DeVelasco G, Lester R, Escudier B, Choueiri TK
Efficacy of targeted therapies after PD-1/PD-L1 blockade in metastatic renal cell carcinoma. Eur J Cancer. 2015 Nov; 51(17):2580-6.
Efficacy of targeted therapies after PD-1/PD-L1 blockade in metastatic renal cell carcinoma.
de Velasco G, Krajewski KM, Albiges L, Awad MM, Bellmunt J, Hodi FS, Choueiri TK
Radiologic Heterogeneity in Responses to Anti-PD-1/PD-L1 Therapy in Metastatic Renal Cell Carcinoma. Cancer Immunol Res. 2016 Jan; 4(1):12-7.
Radiologic Heterogeneity in Responses to Anti-PD-1/PD-L1 Therapy in Metastatic Renal Cell Carcinoma.
Van den Abbeele AD, Krajewski KM, Tirumani SH, Fennessy FM, DiPiro PJ, Nguyen QD, Harris GJ, Jacene HA, Lefever G, Ramaiya NH
Cancer Imaging at the Crossroads of Precision Medicine: Perspective From an Academic Imaging Department in a Comprehensive Cancer Center. J Am Coll Radiol. 2016 Apr; 13(4):365-71.
Cancer Imaging at the Crossroads of Precision Medicine: Perspective From an Academic Imaging Department in a Comprehensive Cancer Center.
Keraliya AR, Krajewski KM, Jagannathan JP, Shinagare AB, Braschi-Amirfarzan M, Tirumani SH, Ramaiya NH
Multimodality imaging of osseous involvement In haematological malignancies. Br J Radiol. 2016; 89(1059):20150980.
Multimodality imaging of osseous involvement In haematological malignancies.
Tirumani SH, Souza D, Krajewski KM, Jagannathan JP, Ramaiya NH, Shinagare AB
Impact of histologic subtype and sarcomatoid transformation on metastasis in renal cell carcinoma: a single institute experience in 149 patients. Abdom Radiol (NY). 2016 Feb; 41(2):295-302.
Impact of histologic subtype and sarcomatoid transformation on metastasis in renal cell carcinoma: a single institute experience in 149 patients.
Kwiatkowski DJ, Choueiri TK, Fay AP, Rini BI, Thorner AR, de Velasco G, Tyburczy ME, Hamieh L, Albiges L, Agarwal N, Ho TH, Song J, Pignon JC, Barrios PM, Michaelson MD, Van Allen E, Krajewski KM, Porta C, Pal S, Bellmunt J, McDermott DF, Heng DYC, Gray KP, Signoretti S
Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma. Clin Cancer Res. 2016 05 15; 22(10):2445-2452.
Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma.
Howard SA, Krajewski KM, Jagannathan JP, Braschi-Amirfarzan M, Tirumani SH, Shinagare AB, Ramaiya NH
A New Look at Toxicity in the Era of Precision Oncology: Imaging Findings, Their Relationship With Tumor Response, and Effect on Metastasectomy. AJR Am J Roentgenol. 2016 Jul; 207(1):4-14.
A New Look at Toxicity in the Era of Precision Oncology: Imaging Findings, Their Relationship With Tumor Response, and Effect on Metastasectomy.
Braschi-Amirfarzan M, Keraliya AR, Krajewski KM, Tirumani SH, Shinagare AB, Hornick JL, Baldini EH, George S, Ramaiya NH, Jagannathan JP
Role of Imaging in Management of Desmoid-type Fibromatosis: A Primer for Radiologists. Radiographics. 2016 May-Jun; 36(3):767-82.
Role of Imaging in Management of Desmoid-type Fibromatosis: A Primer for Radiologists.
Novel imaging in renal cell carcinoma. Curr Opin Urol. 2016 09; 26(5):388-95.
Kelil T, Keraliya AR, Howard SA, Krajewski KM, Braschi-Amirfarzan M, Hornick JL, Ramaiya NH, Tirumani SH
Current Concepts in the Molecular Genetics and Management of Thyroid Cancer: An Update for Radiologists. Radiographics. 2016 Sep-Oct; 36(5):1478-93.
Current Concepts in the Molecular Genetics and Management of Thyroid Cancer: An Update for Radiologists.
Richman DM, Tirumani SH, Hornick JL, Fuchs CS, Howard S, Krajewski K, Ramaiya N, Rosenthal M
Beyond gastric adenocarcinoma: Multimodality assessment of common and uncommon gastric neoplasms. Abdom Radiol (NY). 2017 01; 42(1):124-140.
Beyond gastric adenocarcinoma: Multimodality assessment of common and uncommon gastric neoplasms.
Park KJ, Braschi-Amirfarzan M, DiPiro PJ, Giardino AA, Jagannathan JP, Howard SA, Shinagare AB, Krajewski KM
Multimodality imaging of locally recurrent and metastatic cervical cancer: emphasis on histology, prognosis, and management. Abdom Radiol (NY). 2016 12; 41(12):2496-2508.
Multimodality imaging of locally recurrent and metastatic cervical cancer: emphasis on histology, prognosis, and management.
Krajewski KM, Fougeray R, Choueiri TK, Pons F, Schutz FA, Rosenberg JE, Salhi Y, Bellmunt J
Optimization of the size variation threshold for imaging evaluation of response in patients with platinum-refractory advanced transitional cell carcinoma of the urothelium treated with vinflunine. J Clin Oncol. 2011 May 20; 29(15_suppl):4570.
Optimization of the size variation threshold for imaging evaluation of response in patients with platinum-refractory advanced transitional cell carcinoma of the urothelium treated with vinflunine.
Dabydeen DA, Jagannathan JP, Ramaiya NH, Krajewski KM, Schutz FA, Cho DC, Pedrosa I, Choueiri TK
Pneumonitis associated with mTOR therapy in patients with metastatic renal cell carcinoma: Incidence, radiographic findings, and correlation with clinical outcome. J Clin Oncol. 2011 May 20; 29(15_suppl):e15176.
Pneumonitis associated with mTOR therapy in patients with metastatic renal cell carcinoma: Incidence, radiographic findings, and correlation with clinical outcome.
Park HS, McIntosh L, Braschi-Amirfarzan M, Shinagare AB, Krajewski KM
T-Cell Non-Hodgkin Lymphomas: Spectrum of Disease and the Role of Imaging in the Management of Common Subtypes. Korean J Radiol. 2017 Jan-Feb; 18(1):71-83.
T-Cell Non-Hodgkin Lymphomas: Spectrum of Disease and the Role of Imaging in the Management of Common Subtypes.
DiPiro PJ, Krajewski KM, Giardino AA, Braschi-Amirfarzan M, Ramaiya NH
Radiology Consultation in the Era of Precision Oncology: A Review of Consultation Models and Services in the Tertiary Setting. Korean J Radiol. 2017 Jan-Feb; 18(1):18-27.
Radiology Consultation in the Era of Precision Oncology: A Review of Consultation Models and Services in the Tertiary Setting.
Krajewski KM, Braschi-Amirfarzan M, DiPiro PJ, Jagannathan JP, Shinagare AB
Molecular Targeted Therapy in Modern Oncology: Imaging Assessment of Treatment Response and Toxicities. Korean J Radiol. 2017 Jan-Feb; 18(1):28-41.
Molecular Targeted Therapy in Modern Oncology: Imaging Assessment of Treatment Response and Toxicities.
Alessandrino F, Krajewski KM, Tirumani SH, Braschi-Amirfarzan M, Jagannathan JP, Ramaiya NH, Di Salvo DN
Biliary and pancreatic complications of molecular targeted therapies in cancer imaging. Abdom Radiol (NY). 2017 06; 42(6):1721-1733.
Biliary and pancreatic complications of molecular targeted therapies in cancer imaging.
Jacobus SJ, Qu AQ, Sweeney C, Appleman LJ, Tretter CP, Bubley GJ, Elfiky A, Park R, Stack EC, Signoretti S, Walsh MK, Steele G, Hirsch MS, Krajewski KM, Taplin ME, Rosenberg JE, Ross RW
A phase II multicenter study of neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin (ddMVAC) chemotherapy with pegfilgrastim support in patients (pts) muscle-invasive urothelial cancer (MIUC): Safety, pathologic, radiologic, and molecular correlates. J Clin Oncol. 2013 Feb 20; 31(6_suppl):278.
A phase II multicenter study of neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin (ddMVAC) chemotherapy with pegfilgrastim support in patients (pts) muscle-invasive urothelial cancer (MIUC): Safety, pathologic, radiologic, and molecular correlates.
Choueiri TK, Jacobus SJ, Rosenberg JE, Ramaiya NH, Krajewski KM
Radiologic response (RR) by MRI in patients (pts) with muscle-invasive urothelial cancer (MIUC) undergoing neoadjuvant chemotherapy. J Clin Oncol. 2013 Feb 20; 31(6_suppl):283.
Radiologic response (RR) by MRI in patients (pts) with muscle-invasive urothelial cancer (MIUC) undergoing neoadjuvant chemotherapy.
Saboo SS, Krajewski KM, Jagannathan JP, O'Regan KN, Odze R, Ramaiya N, Wolpin BM
Rapid progression of combined hepatocellular carcinoma and cholangiocarcinoma. Cancer Imaging. 2011 Mar 31; 11:37-41.
Rapid progression of combined hepatocellular carcinoma and cholangiocarcinoma.
Saboo SS, Krajewski KM, Jagannathan JP, Ramaiya N
IVC tumor thrombus: an advanced case of rare extraosseous Ewing sarcoma of the adrenal gland. Urology. 2012 Jun; 79(6):e77-8.
IVC tumor thrombus: an advanced case of rare extraosseous Ewing sarcoma of the adrenal gland.
Reynolds TH, Krajewski KM, Larkin LM, Reid P, Halter JB, Supiano MA, Dengel DR
The journals of gerontology. Series A, Biological sciences and medical sciences
Effect of age on skeletal muscle proteolysis in extensor digitorum longus muscles of B6C3F1 mice. J Gerontol A Biol Sci Med Sci. 2002 May; 57(5):B198-201.
Effect of age on skeletal muscle proteolysis in extensor digitorum longus muscles of B6C3F1 mice.
Alessandrino F, Tirumani SH, Krajewski KM, Shinagare AB, Jagannathan JP, Ramaiya NH, Di Salvo DN
Imaging of hepatic toxicity of systemic therapy in a tertiary cancer centre: chemotherapy, haematopoietic stem cell transplantation, molecular targeted therapies, and immune checkpoint inhibitors. Clin Radiol. 2017 Jul; 72(7):521-533.
Imaging of hepatic toxicity of systemic therapy in a tertiary cancer centre: chemotherapy, haematopoietic stem cell transplantation, molecular targeted therapies, and immune checkpoint inhibitors.
Choe J, Braschi-Amirfarzan M, Tirumani SH, Shinagare AB, Kim KW, Ramaiya NH, Krajewski KM
Updates for the radiologist in non-muscle-invasive, muscle-invasive, and metastatic bladder cancer. Abdom Radiol (NY). 2017 11; 42(11):2710-2724.
Updates for the radiologist in non-muscle-invasive, muscle-invasive, and metastatic bladder cancer.
Shy ME, Blake J, Krajewski K, Fuerst DR, Laura M, Hahn AF, Li J, Lewis RA, Reilly M
Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology. 2005 Apr 12; 64(7):1209-14.
Reliability and validity of the CMT neuropathy score as a measure of disability.
Thornton E, Howard SA, Jagannathan J, Krajewski KM, Shinagare AB, O'Regan K, Cleary JM, Ramaiya NH
Imaging features of bowel toxicities in the setting of molecular targeted therapies in cancer patients. Br J Radiol. 2012 Oct; 85(1018):1420-6.
Imaging features of bowel toxicities in the setting of molecular targeted therapies in cancer patients.
Shah SH, Jagannathan JP, Krajewski K, O'Regan KN, George S, Ramaiya NH
Uterine sarcomas: then and now. AJR Am J Roentgenol. 2012 Jul; 199(1):213-23.
Krajewski KM, Howard SA, Shinagare AB, Van den Abbeele AD, Fennessy FM
Cancer Imaging Fellowship Training: Utility and Added Value in the Modern Era. J Am Coll Radiol. 2017 10; 14(10):1345-1348.
Cancer Imaging Fellowship Training: Utility and Added Value in the Modern Era.
Saboo SS, Krajewski KM, Shinagare AB, Jagannathan JP, Hornick JL, Ramaiya N
Imaging features of primary extranodal histiocytic sarcoma: report of two cases and a review of the literature. Cancer Imaging. 2012 Aug 10; 12:253-8.
Imaging features of primary extranodal histiocytic sarcoma: report of two cases and a review of the literature.
Howard S, O'Regan K, Jagannathan J, Krajewski K, Giardino A, Ramaiya N
Extrapulmonary small cell carcinoma: a pictorial review. AJR Am J Roentgenol. 2011 Sep; 197(3):W392-8.
Extrapulmonary small cell carcinoma: a pictorial review.
Saboo SS, Krajewski KM, Zukotynski K, Howard S, Jagannathan JP, Hornick JL, Ramaiya N
Imaging features of primary and secondary adult rhabdomyosarcoma. AJR Am J Roentgenol. 2012 Dec; 199(6):W694-703.
Imaging features of primary and secondary adult rhabdomyosarcoma.
Parithivel K, Jagannathan JP, Krajewski K, O'Regan K, Quick CM, Ramaiya N, Campos S
Ovarian squamous cell carcinoma arising from mature cystic teratoma. Cancer Imaging. 2011 Jun 15; 11:67-9.
Ovarian squamous cell carcinoma arising from mature cystic teratoma.
Saboo SS, Jagannathan JP, Krajewski KM, O'Regan K, Hornick JL, Fisher DC, Ramaiya N
Symptomatic extranodal Rosai-Dorfman disease treated with steroids, radiation, and surgery. J Clin Oncol. 2011 Nov 01; 29(31):e772-5.
Symptomatic extranodal Rosai-Dorfman disease treated with steroids, radiation, and surgery.
Thornton E, Krajewski KM, O'Regan KN, Giardino AA, Jagannathan JP, Ramaiya N
Imaging features of primary and secondary malignant tumours of the sacrum. Br J Radiol. 2012 Mar; 85(1011):279-86.
Imaging features of primary and secondary malignant tumours of the sacrum.
Krajewski KM, Fougeray R, Bellmunt J, Pons F, Schutz FA, Rosenberg JE, Salhi Y, Choueiri TK
Optimisation of the size variation threshold for imaging evaluation of response in patients with platinum-refractory advanced transitional cell carcinoma of the urothelium treated with vinflunine. Eur J Cancer. 2012 Jul; 48(10):1495-502.
Optimisation of the size variation threshold for imaging evaluation of response in patients with platinum-refractory advanced transitional cell carcinoma of the urothelium treated with vinflunine.
Shinagare AB, Zukotynski KA, Krajewski KM, Jagannathan JP, Butrynski J, Hornick JL, Ramaiya NH
Esophageal gastrointestinal stromal tumor: report of 7 patients. Cancer Imaging. 2012 Apr 27; 12:100-8.
Esophageal gastrointestinal stromal tumor: report of 7 patients.
Koch MR, Jagannathan JP, Shinagare AB, Krajewski KM, Raut CP, Hornick JL, Ramaiya NH
Imaging features of primary anorectal gastrointestinal stromal tumors with clinical and pathologic correlation. Cancer Imaging. 2013 Feb 08; 12:557-65.
Imaging features of primary anorectal gastrointestinal stromal tumors with clinical and pathologic correlation.
Moreira RB, Hamieh L, Gjini E, Lako A, Krajewski KM, Yoon CH, Ott PA
Regression of multifocoal in transit melanoma metastases after palliative resection of dominant masses and 2 years after treatment with ipilimumab. J Immunother Cancer. 2017 07 18; 5(1):61.
Regression of multifocoal in transit melanoma metastases after palliative resection of dominant masses and 2 years after treatment with ipilimumab.
Sneag DB, Krajewski K, Giardino A, O'Regan KN, Shinagare AB, Jagannathan JP, Ramaiya N
Extrahepatic spread of hepatocellular carcinoma: spectrum of imaging findings. AJR Am J Roentgenol. 2011 Oct; 197(4):W658-64.
Extrahepatic spread of hepatocellular carcinoma: spectrum of imaging findings.
Saboo SS, Zukotynski K, Shinagare AB, Krajewski KM, Ramaiya N
Anal carcinoma: FDG PET/CT in staging, response evaluation, and follow-up. Abdom Imaging. 2013 Aug; 38(4):728-35.
Anal carcinoma: FDG PET/CT in staging, response evaluation, and follow-up.
Howard SA, Krajewski KM, Thornton E, Jagannathan JP, O'Regan K, Cleary J, Ramaiya N
Decade of molecular targeted therapy: abdominal manifestations of drug toxicities--what radiologists should know. AJR Am J Roentgenol. 2012 Jul; 199(1):58-64.
Decade of molecular targeted therapy: abdominal manifestations of drug toxicities--what radiologists should know.
Parithivel K, Ramaiya N, Jagannathan JP, O'Regan K, Krajewski K, Fisher D, Choueiri TK, Jacobsen E
Everolimus- and temsirolimus-associated enteritis: report of three cases. J Clin Oncol. 2011 May 10; 29(14):e404-6.
Everolimus- and temsirolimus-associated enteritis: report of three cases.
Nishino M, Jagannathan JP, Krajewski KM, O'Regan K, Hatabu H, Shapiro G, Ramaiya NH
Personalized tumor response assessment in the era of molecular medicine: cancer-specific and therapy-specific response criteria to complement pitfalls of RECIST. AJR Am J Roentgenol. 2012 Apr; 198(4):737-45.
Personalized tumor response assessment in the era of molecular medicine: cancer-specific and therapy-specific response criteria to complement pitfalls of RECIST.
Chikarmane SA, Khurana B, Krajewski KM, Shinagare AB, Howard S, Sodickson A, Jagannathan J, Ramaiya N
What the emergency radiologist needs to know about treatment-related complications from conventional chemotherapy and newer molecular targeted agents. Emerg Radiol. 2012 Dec; 19(6):535-46.
What the emergency radiologist needs to know about treatment-related complications from conventional chemotherapy and newer molecular targeted agents.
Suh CH, Kim KW, Park SH, Shin S, Ahn J, Pyo J, Shinagare AB, Krajewski KM, Ramaiya NH
A cost-effectiveness analysis of the diagnostic strategies for differentiating focal nodular hyperplasia from hepatocellular adenoma. Eur Radiol. 2018 Jan; 28(1):214-225.
A cost-effectiveness analysis of the diagnostic strategies for differentiating focal nodular hyperplasia from hepatocellular adenoma.
Shinagare AB, Ramaiya NH, Jagannathan JP, Krajewski KM, Giardino AA, Butrynski JE, Raut CP
A to Z of desmoid tumors. AJR Am J Roentgenol. 2011 Dec; 197(6):W1008-14.
Kamran SC, Howard SA, Shinagare AB, Krajewski KM, Jagannathan JP, Hornick JL, Ramaiya NH
Malignant peripheral nerve sheath tumors: prognostic impact of rhabdomyoblastic differentiation (malignant triton tumors), neurofibromatosis 1 status and location. Eur J Surg Oncol. 2013 Jan; 39(1):46-52.
Malignant peripheral nerve sheath tumors: prognostic impact of rhabdomyoblastic differentiation (malignant triton tumors), neurofibromatosis 1 status and location.
Shinagare AB, Guo M, Hatabu H, Krajewski KM, Andriole K, Van den Abbeele AD, DiPiro PJ, Nishino M
Incidence of pulmonary embolism in oncologic outpatients at a tertiary cancer center. Cancer. 2011 Aug 15; 117(16):3860-6.
Incidence of pulmonary embolism in oncologic outpatients at a tertiary cancer center.
Tirumani SH, Jagannathan JP, O'Regan K, Kim KW, Shinagare AB, Krajewski KM, Ramaiya NH
Molecular targeted therapies in non-GIST soft tissue sarcomas: what the radiologist needs to know. Cancer Imaging. 2013 May 02; 13:197-211.
Molecular targeted therapies in non-GIST soft tissue sarcomas: what the radiologist needs to know.
Lalani AA, Xie W, Martini DJ, Steinharter JA, Norton CK, Krajewski KM, Duquette A, Bossé D, Bellmunt J, Van Allen EM, McGregor BA, Creighton CJ, Harshman LC, Choueiri TK
Change in Neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma. J Immunother Cancer. 2018 01 22; 6(1):5.
Change in Neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma.
Viteri Malone MA, Ares GR, De Velasco G, Brandão R, Lin X, Norton C, Simantov R, Moslehi J, Krajewski KM, Choueiri TK, McKay RR
The Clinical Presentation, Survival Outcomes, and Management of Patients With Renal Cell Carcinoma and Cardiac Metastasis Without Inferior Vena Cava Involvement: Results From a Pooled Clinical Trial Database and Systematic Review of Reported Cases. Clin Genitourin Cancer. 2018 04; 16(2):e327-e333.
The Clinical Presentation, Survival Outcomes, and Management of Patients With Renal Cell Carcinoma and Cardiac Metastasis Without Inferior Vena Cava Involvement: Results From a Pooled Clinical Trial Database and Systematic Review of Reported Cases.
Krajewski KM, Giardino AA, Zukotynski K, Van den Abbeele AD, Pedrosa I
Imaging in renal cell carcinoma. Hematol Oncol Clin North Am. 2011 Aug; 25(4):687-715.
Sneag DB, Krajewski KM, Howard S, Jagannathan JP, Star KV, Ramaiya N
Sclerotic osseous metastases from renal cell carcinoma. Skeletal Radiol. 2012 Sep; 41(9):1169-75.
Sclerotic osseous metastases from renal cell carcinoma.
Kurra V, Krajewski KM, Jagannathan J, Giardino A, Berlin S, Ramaiya N
Typical and atypical metastatic sites of recurrent endometrial carcinoma. Cancer Imaging. 2013 Mar 26; 13:113-22.
Typical and atypical metastatic sites of recurrent endometrial carcinoma.